BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24608078)

  • 1. Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement.
    Wu SY; McCavit TL; Cederberg K; Galindo RL; Leavey PJ
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):402-5. PubMed ID: 24608078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infantile myofibromatosis.
    Larralde M; Ferrari B; Martinez JP; Barbieri MAF; Méndez JH; Casas J
    An Bras Dermatol; 2017; 92(6):854-857. PubMed ID: 29364448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse presentation and tailored treatment of infantile myofibromatosis: A single-center experience.
    Manisterski M; Benish M; Levin D; Shiran SI; Sher O; Gortzak Y; Elhasid R
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28769. PubMed ID: 33063933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
    Gandhi MM; Nathan PC; Weitzman S; Levitt GA
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):750-4. PubMed ID: 12972815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy.
    Gehle S; Quinsey C; McShane D; Thompson P; Quezada G
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):e921-e923. PubMed ID: 37526359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
    Bidadi B; Watson A; Weigel B; Oliveira A; Kirkham J; Arndt C
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28288. PubMed ID: 32307894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis.
    Proust S; Benchimol G; Fraitag S; Starck J; Giacobbi V; Pierron G; Bodemer C; Orbach D
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28576. PubMed ID: 32896962
    [No Abstract]   [Full Text] [Related]  

  • 8. First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate.
    Azzam R; Abboud M; Muwakkit S; Khoury N; Saab R
    Pediatr Blood Cancer; 2009 Feb; 52(2):308. PubMed ID: 18937326
    [No Abstract]   [Full Text] [Related]  

  • 9. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
    Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J
    BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options.
    Weaver MS; Navid F; Huppmann A; Meany H; Angiolillo A
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):237-41. PubMed ID: 25389917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile myofibromatosis: a case report and review of the literature.
    Ang P; Tay YK; Walford NQ
    Cutis; 2004 Apr; 73(4):229-31. PubMed ID: 15134320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile myofibromatosis.
    Ariffin H; Teh KH; Looi LM; Ariffin WA; Lin HP
    Med J Malaysia; 2001 Dec; 56(4):497-9. PubMed ID: 12014771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief report: successful therapy of a patient with infantile generalized myofibromatosis.
    Day M; Edwards AO; Weinberg A; Leavey PJ
    Med Pediatr Oncol; 2002 May; 38(5):371-3. PubMed ID: 11979466
    [No Abstract]   [Full Text] [Related]  

  • 14. Infantile myofibromatosis: a series of 28 cases.
    Mashiah J; Hadj-Rabia S; Dompmartin A; Harroche A; Laloum-Grynberg E; Wolter M; Amoric JC; Hamel-Teillac D; Guero S; Fraitag S; Bodemer C
    J Am Acad Dermatol; 2014 Aug; 71(2):264-70. PubMed ID: 24894456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile myofibromatosis: report on a family with autosomal dominant inheritance and variable penetrance.
    Kulkarni K; Desai S; Grundy P; Sergi C
    J Pediatr Surg; 2012 Dec; 47(12):2312-5. PubMed ID: 23217896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic Overlap between Infantile Myofibromatosis and Infantile Fibrosarcoma: A Pitfall in Diagnosis.
    Alaggio R; Barisani D; Ninfo V; Rosolen A; Coffin CM
    Pediatr Dev Pathol; 2008; 11(5):355-62. PubMed ID: 19006426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital myofibromatosis in two siblings.
    Arcangeli F; Calista D
    Eur J Dermatol; 2006; 16(2):181-3. PubMed ID: 16581573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric infantile myofibromatosis: two perinatal cases.
    Pelluard-Nehmé F; Coatleven F; Carles D; Alberti EM; Briex M; Dallay D
    Eur J Pediatr; 2007 Oct; 166(10):997-1001. PubMed ID: 17186271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent infantile myofibromatosis: a report of conservative management and discussion of treatment strategies.
    Ebert CS; Zdanski C; Ardeshirpour F; Patel M; Hart CF; Drake AF
    Ear Nose Throat J; 2008 Dec; 87(12):E4. PubMed ID: 19105133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized infantile myofibromatosis with a monophasic primitive pattern.
    Iwafuchi H; Tsuzuki T; Ito R; Miyake H; Okita H; Hamazaki M
    Pathol Int; 2015 Aug; 65(8):432-7. PubMed ID: 25989870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.